Amino acid replacement: Q395term.
The premature stop codon is just before a sterol-sensing domain.
C8661342T
C?T
Q395term | ptc-PA
Q395term
In ptcD130, ptc16/ptcD130 and ptcD130/Df(2R)ED1742 mutant embryos, ganglionic branches do not extend into the ventral nerve cord. Defects in the dorsal branch, elongation and in dorsal trunk thickness and convolution are also observed. In addition, the visceral branches are very often misplaced, localising more ventrally than in the wild-type.
Tracheal development begins normally in ptcD130 mutant embryos. Placodes are correctly positioned and the first steps of cell migration occur normally. The initial steps of tracheal development are apparently regular until embryonic stage 12. At this point, the first defects in ganglionic branch extension are observed. In mutant stage 15 embryos, the anterior lateral trunk and ganglionic branch fail to separate. Despite this, ptcD130 mutant embryos display the same anterior and posterior lateral trunk/ganglionic branch extensions as in wild-type, by the end of embryogenesis.
From placode stages, ptcD130 mutants show a lower number of tracheal cells than wild-type embryos. On average, 63 cells are found in each tracheal metamere 5 in stage 13 embryos in ptcD130 mutants, in comparison with 97 cells in wild-type embryos.
ptcD130 has abnormal cell migration phenotype, suppressible by sr155/sr[+]
ptcD130 has abnormal cell migration phenotype, non-suppressible by hh21
ptcD130 has abnormal cell migration phenotype, non-suppressible by sr155
ptcD130 has abnormal cell migration phenotype, non-suppressible by Df(3L)H99
ptcD130 has abnormal cell migration phenotype, non-suppressible by bs03267
ptc[+]/ptcD130 is a suppressor of abnormal cell migration phenotype of bnl00857
hh21, ptcD130 has abnormal cell migration phenotype
ptcD130 has embryonic/larval tracheal system phenotype, suppressible by sr155/sr[+]
ptcD130 has embryonic/larval ganglionic tracheal branch phenotype, suppressible by sr155/sr[+]
ptcD130 has embryonic/larval tracheal system phenotype, non-suppressible by Df(3L)H99
ptcD130 has embryonic/larval ganglionic tracheal branch phenotype, non-suppressible by Df(3L)H99
ptcD130 has embryonic/larval tracheal system phenotype, non-suppressible by bs03267
ptcD130 has embryonic/larval ganglionic tracheal branch phenotype, non-suppressible by bs03267
ptcD130 has embryonic/larval tracheal system phenotype, non-suppressible by hh21
ptcD130 has embryonic/larval ganglionic tracheal branch phenotype, non-suppressible by hh21
ptcD130 has embryonic/larval tracheal system phenotype, non-suppressible by sr155
ptcD130 has embryonic/larval ganglionic tracheal branch phenotype, non-suppressible by sr155
ptc[+]/ptcD130 is a suppressor of embryonic/larval ganglionic tracheal branch phenotype of bnl00857
ptc[+]/ptcD130 is a suppressor of embryonic/larval tracheal system phenotype of bnl00857
hh21, ptcD130 has embryonic/larval ganglionic tracheal branch phenotype
ptcD130/Df(3L)H99 mutant embryos maintain the same phenotype as ptcD130 homozygotes, with tracheal ganglionic branches failing to extend into the ventral nerve cord, despite the absence of cell death.
ptcD130 mutant ganglionic branch cells are still unable to migrate towards the ventral nerve cord, in a bs03267 mutant background.
A ptcD130 heterozygous mutant background suppresses the tracheal ganglionic branch migration defects seen in bnl00857 mutants.
In ptcD130/hh21 double mutant embryos, tracheal ganglionic branch migration is disrupted as it is in ptcD130 single mutants.
Removing one copy of sr in a ptcD130 background rescues the migration of many ganglionic branches, whereas double mutant embryos exhibit impaired ganglionic branch migration.